Saccharomyces boulardii promoters for control of gene expression in vivo
Abstract Background Interest in the use of engineered microbes to deliver therapeutic activities has increased in recent years. The probiotic yeast Saccharomyces boulardii has been investigated for production of therapeutics in the gastrointestinal tract. Well-characterised promoters are a prerequis...
Main Authors: | Carmen Sands, Karl Alex Hedin, Ruben Vazquez-Uribe, Morten Otto Alexander Sommer |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | Microbial Cell Factories |
Online Access: | https://doi.org/10.1186/s12934-023-02288-8 |
Similar Items
-
Biocontainment strategies for in vivo applications of Saccharomyces boulardii
by: Karl Alex Hedin, et al.
Published: (2023-02-01) -
Effects of broad-spectrum antibiotics on the colonisation of probiotic yeast Saccharomyces boulardii in the murine gastrointestinal tract
by: Karl Alex Hedin, et al.
Published: (2022-05-01) -
Beneficial properties of probiotic yeast Saccharomyces boulardii
by: Tomičić Zorica M., et al.
Published: (2016-01-01) -
Role of Saccharomyces boulardii in Reduction of Neonatal Hyperbilirubinemia
by: V. Suganthi, et al.
Published: (2016-11-01) -
The effect of probiotic nutrition of Saccharomyces boulardii and Saccharomyces cerevisiae on yield, antioxidant activity and expression of interleukin-6 gene in Holstein calves
by: S. Sabooni, et al.
Published: (2020-12-01)